Stock NGNE NEUROGENE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Neurogene Inc.

Equities

NGNE

US64135M1053

Market Closed - Nasdaq
Other stock markets
 21:00:00 28/05/2024 BST 		5-day change 1st Jan Change
31.71 USD -1.25% Intraday chart for Neurogene Inc. -2.49% +63.62%
05-10 Neurogene Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-07 Neurogene Presents Favorable Safety Data from Phase 1/2 Trial of Ngn-401 Gene Therapy for Rett Syndrome During Asgct Annual Meeting CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROGENE INC.
Other Biotechnology & Medical Research
-1.25%-2.49%+63.62% - - 408M
Neutral
Bullish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. NGNE Stock
  4. Charts Neurogene Inc.
  5. Comparison Chart